CLOCK and cancer: Examples include CLK8, which disrupts BMAL1/CLOCK interactions,99 and compounds like a derivative of 2-ethoxypropanoic acid and ARN5187, which target CRY1/2 and REV-ERBβ proteins,100 showing promise for treating circadian disorders and cancer.